Skip to Main Content

Paper Details

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
J Thorac Oncol
0
2024
Author NameAffiliation
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2